ArticleJournal of lipid research2026
The impact of charge on chlorpromazine interaction with lipid membranes.
Article in Journal of lipid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychiatric disorders, such as schizophrenia, are treated with antipsychotics. One such molecule is chlorpromazine (CPZ) that mainly exerts its therapeutic effect via its antagonist activity on the dopamine D2 receptor. Due to its high lipophilicity, it can partition and accumulate in membranes, which can lead to a delayed full clinical effect, reached weeks after the beginning of treatment. CPZ's insertion in membranes impacts the bilayer's physicochemical properties, which can indirectly impact membrane-embedded receptors, such as the D2 receptor. To further delve into the potential role of phosphatidylserine (PS) in CPZ-membrane interaction and subsequent remodeling of membrane properties, we have investigated CPZ interactions with phosphatidylcholine bilayers, a common model zwitterionic lipid, in the absence and presence of 10% PS. The study provides a comprehensive overview of CPZ's preferential interaction with PS-containing membranes. Altogether, data from complementary techniques showed a higher affinity of CPZ for PS headgroups, enhanced PS-mediated penetration in the membrane, and higher drug retention within the anionic lipid bilayer compared with POPC alone. At high concentration, CPZ induced the formation of mixed micelles on the surface of the treated membranes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.